Status:
COMPLETED
Carotid PET/MRI With DOTATATE in Patients Post Head and Neck Radiation Therapy
Lead Sponsor:
University Health Network, Toronto
Conditions:
Head & Neck Cancer
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
The improvement of comprehensive multi-modality treatment and radiotherapy (RT) technology has resulted in an improved survival rate of head and neck malignancies within recent decades. As survival in...
Eligibility Criteria
Inclusion
- previously treated with radiation for head and neck malignancy;
- Age Group: ≥30 years;
- Patients who have no contraindications to PET/MRI;
- No allergy to contrast agents.
Exclusion
- Pregnant females;
- Age group: \< 30 years;
- Allergy to MR contrast agents;
- Pacemakers/ICD/Claustrophobic patients.
Key Trial Info
Start Date :
August 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04040166
Start Date
August 22 2019
End Date
April 15 2021
Last Update
December 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G 2M9